This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Is Celanese (CE) Down 20.3% Since Last Earnings Report?
by Zacks Equity Research
Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Celanese Partners Henkel for Adhesives Made of Captured CO2 Emissions
by Zacks Equity Research
CE commenced a CCU project at its Clear Lake facility earlier this year as part of its Fairway Methanol joint venture with Mitsui & Co., Ltd.
Should You Invest in the First Trust Materials AlphaDEX ETF (FXZ)?
by Zacks Equity Research
Sector ETF report for FXZ
Celanese's Q3 Earnings and Revenues Miss Estimates, Decline Y/Y
by Zacks Equity Research
CE witnesses sustained demand weakness in major end-markets such as paints, coatings and construction in Q3.
Celanese (CE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Celanese (CE) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Celanese (CE) delivered earnings and revenue surprises of -14.08% and 1.38%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
AdvanSix (ASIX) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
AdvanSix (ASIX) delivered earnings and revenue surprises of 33.33% and 11.33%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Celanese to Report Q3 Earnings: What's in the Offing for the Stock?
by Zacks Equity Research
CE's cost-cutting initiatives and acquisition synergies are likely to have contributed to its Q3 performance amid demand and pricing headwinds.
Celanese (CE) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Celanese (CE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.
CSW Industrials (CSWI) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
CSW Industrials (CSWI) delivered earnings and revenue surprises of 3.20% and 4.58%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Celanese (CE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bear Of The Day: Celanese (CE)
by Brian Bolan
Folliwng a recent earnings miss, earnings estimates have dropped for this stock
Eastman Chemical Gains on Cost Actions & Innovation Amid Demand Woes
by Zacks Equity Research
While EMN faces headwinds from weak demand and inventory de-stocking in certain markets, it benefits from cost management, pricing actions and innovation.
FMC Stock Gains on New Products and Cost-reduction Actions
by Zacks Equity Research
FMC benefits from its efforts to expand its product portfolio through new product launches and restructuring and cost-reduction actions.
Ingevity (NGVT) Soars 12.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Ingevity (NGVT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Eastman (EMN) Gains on Cost Cuts & Innovation Amid Demand Woes
by Zacks Equity Research
Eastman Chemical (EMN) benefits from cost-management actions, acquisitions and innovation amid challenges from weak demand in certain markets.
Chemours (CC) Opens Cutting-Edge Facility for EV Batteries
by Zacks Equity Research
Chemours (CC) opens the Chemours Battery Innovation Center to advance sustainable battery technology for electric vehicles.
Are Options Traders Betting on a Big Move in Celanese (CE) Stock?
by Zacks Equity Research
Investors need to pay close attention to Celanese (CE) stock based on the movements in the options market lately.
Celanese (CE) Q2 Earnings and Sales Fall Short of Estimates
by Zacks Equity Research
The decline in net sales of Celanese (CE) in Q2 is a result of a decrease in pricing.
Celanese (CE) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Celanese (CE) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Celanese (CE) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Celanese (CE) delivered earnings and revenue surprises of -15% and 2.74%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Can These 4 Chemical Stocks Hit Targets This Earnings Season?
by Anindya Barman
Chemical companies are expected to have benefited from demand recovery across key end markets and moderated de-stocking activities. Let's see how APD, CE, CC and AXTA are poised ahead of their earnings releases.
Unveiling Celanese (CE) Q2 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Celanese (CE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
Green Plains Renewable Energy (GPRE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Green Plains (GPRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celanese (CE) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Celanese's (CE) investment in high-return organic projects, cost-cutting initiatives, and acquisition synergies are likely to have contributed to its Q2 performance amid demand and pricing headwinds.